Literature DB >> 19108546

The trials of the returning traveler: ciprofloxacin failure in enteric fever.

Alison M Bormann1, David R Boulware.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108546      PMCID: PMC2768140     

Source DB:  PubMed          Journal:  Minn Med        ISSN: 0026-556X


× No keyword cloud information.
  5 in total

1.  Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.

Authors:  V Manchanda; P Bhalla; M Sethi; V K Sharma
Journal:  Indian J Med Microbiol       Date:  2006-04       Impact factor: 0.985

2.  Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.

Authors:  Tzonyo Dimitrov; Edet E Udo; Osama Albaksami; Abdul A Kilani; El-Din M R Shehab
Journal:  J Med Microbiol       Date:  2007-02       Impact factor: 2.472

3.  Spectrum of disease and relation to place of exposure among ill returned travelers.

Authors:  David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

4.  Travel medicine considerations for North American immigrants visiting friends and relatives.

Authors:  Nina Bacaner; Bill Stauffer; David R Boulware; Patricia F Walker; Jay S Keystone
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

5.  Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.

Authors:  Robert Slinger; Marc Desjardins; Anne E McCarthy; Karam Ramotar; Peter Jessamine; Christiane Guibord; Baldwin Toye
Journal:  BMC Infect Dis       Date:  2004-09-20       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.